BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 923459)

  • 1. [Influence of molsidomine on exercise-ECG'S In coronary insufficiency (author's transl)].
    Grewe N; Stauch M
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1758-63. PubMed ID: 923459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of molsidomine on haemodynamics at rest and on exercise in patients who have coronary heart disease (author's transl)].
    Niehues B; Krimmel W; Hombach V; Tauchert M; Behrenbeck DW; Hilger HH
    Dtsch Med Wochenschr; 1978 May; 103(20):853-6. PubMed ID: 648365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The normalizing effect of ECG in exercise tolerance tests under molsidomine in different dosages (author's transl].
    Jansen E; Klepzig H
    Med Klin; 1978 Jun; 73(26):983-6. PubMed ID: 672755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circadian variation of ischaemic ST lowering in exercise ECG (author's transl)].
    Strasser R; Klepzig H
    Dtsch Med Wochenschr; 1981 Apr; 106(14):424-7. PubMed ID: 6894277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
    Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
    Messin R; Demaret B; Denolin H
    Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molsidomine in the long-term treatment of angina pectoris].
    Blasini R; Brügmann U; Mannes A; Rudolph W
    Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.